Pms-Sodium Polystyrene Sulfonate and Tivicay (Dolutegravir 10 mg)
Determining the interaction of Pms-Sodium Polystyrene Sulfonate and Tivicay (Dolutegravir 10 mg) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Tivicay
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pms-Sodium Polystyrene Sulfonate-Tivicay (Dolutegravir 25 mg and 50 mg)
- Pms-Sodium Polystyrene Sulfonate-Tivorbex
- Pms-Sodium Polystyrene Sulfonate-Tizanidine
- Pms-Sodium Polystyrene Sulfonate-Tizanidine Capsules
- Pms-Sodium Polystyrene Sulfonate-Tizanidine Hydrochloride
- Pms-Sodium Polystyrene Sulfonate-TL Fluorivitamin
- Tivicay (Dolutegravir 10 mg)-Pneumococcal 13-valent conjugate vaccine
- Tivicay (Dolutegravir 10 mg)-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Tivicay (Dolutegravir 10 mg)-Pneumococcal Conjugate Vaccine (13-Valent)
- Tivicay (Dolutegravir 10 mg)-Pneumococcal Conjugate Vaccine (7-Valent)
- Tivicay (Dolutegravir 10 mg)-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Tivicay (Dolutegravir 10 mg)-Pneumococcal polysaccharides vaccine (PPSV), 23-valent